CMB
Click for more information
11.4% 35.0¢ cambium bio limited

Ann: Australian Biomarker Patent Allowed, page-2

  1. Biotechasx
    172 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    01/10/20
    09:21
    Post #: 47763247
    That's great news, and I would have liked to hear more about this patent for MSC treatments developed by others. For instance, if this patent can be used to monitor Mesoblast (ASX:MSB) efficiency, this could lead to a partnership with the leader in this field, and therefore bring attention to RGS from MSB investors.
    RGS Price at posting: 15.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
35.0¢ 		Change
-0.045(11.4%) 		Mkt cap ! $4.175M
Open High Low Value Volume
39.0¢ 39.0¢ 35.0¢ $46 127

Buyers (Bids)

No. Vol. Price($)
1 75 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 13.58pm 09/08/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.